37 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Rank Status Study
1 Recruiting Effect of Vitamin K Supplementation on Markers of Diabetes Risk in Obese Children
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
2 Unknown  Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
3 Recruiting The Effects of Vitamin K2 Supplementation on the Progression of Coronary Artery Calcification
Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Menaquinone-7 (Vitamin K2);   Other: Placebo capsules
4 Unknown  Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
Condition: Folliculitis
Intervention: Other: Vitamin K3
5 Unknown  Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
Conditions: Kidney Diseases;   Coronary Artery Calcification
Interventions: Drug: Vitamin K2+10μg cholecalciferol;   Drug: Vitamin D
6 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
7 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Vitamin K1 to Slow the Progression of Thoracic Aortic and Coronary Artery Calcification
Intervention: Drug: Vitamin K1
8 Recruiting Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification
Condition: Aortic Valve Calcification
Intervention: Dietary Supplement: Vitamin K supplementation
9 Not yet recruiting Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
Conditions: Carotid Disease;   Atherosclerosis
Intervention: Drug: Vitamin K2 (Menaquinone)
10 Recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
11 Unknown  Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery
Conditions: Bleeding;   Complications
Intervention: Drug: Phytonadione
12 Recruiting A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
Condition: Atrial Fibrillation
Interventions: Drug: rivaroxaban;   Drug: uninterrupted vitamin K antagonist (VKA)
13 Not yet recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
14 Recruiting Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Condition: Cervical Artery Dissection
Interventions: Drug: Acetylsalicylic acid;   Drug: vitamin K-antagonist
15 Recruiting Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
Conditions: Venous Thromboembolism;   Neoplasms
Interventions: Drug: low molecular weight heparin;   Drug: vitamin K antagonists
16 Unknown  Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream
Condition: Metastatic Colorectal Cancer
Interventions: Device: Reconval K1 Cream;   Device: Reconval Cream
17 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
18 Recruiting Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
19 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
20 Recruiting Anti Vitamin K Therapeutic Education
Condition: Cardio-vascular Diseases
Intervention: Other: therapeutic education program

Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results
Indicates status has not been verified in more than two years